Chapters

Transcript

Video

What common mutations and rearrangements--among them EGFR, ALK, HER2, BRAF, RAS, MET, RET and ROS-- present in tumors represent the best molecular targets for cancer therapy?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Professsor Hyun Cheol Chung, MD

Professsor Hyun Cheol Chung, MD

Professor of Medical Oncology
Director, Yonsei Song-Dang Institute for Cancer Research
Yonsei University College of Medicine
Seoul, Korea